The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 randomized open-label study of oral darolutamide monotherapy vs. androgen deprivation therapy in men with hormone-naive prostate cancer (EORTC-GUCG 1532).
 
Bertrand F. Tombal
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Myovant Sciences; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen; Myovant Sciences; Pfizer/Astellas; Sanofi; Steba Biotech; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Astellas Pharma; Janssen
Research Funding - Ferring (Inst)
Expert Testimony - Steba Biotech
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi
 
Francisco Gomez-Veiga
No Relationships to Disclose
 
Alvaro Gomez-Ferrer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology
Speakers' Bureau - Astellas Oncology; Bayer; Janssen Medical Affairs; Recordati
Travel, Accommodations, Expenses - Astellas Amgen BioPharama; Bayer; Janssen; Recordati
 
Fernando López-Campos
No Relationships to Disclose
 
Piet Ost
Consulting or Advisory Role - Astellas Pharma; Bayer; Curium Pharma; Janssen-Cilag; Novartis; Telix Pharmaceuticals
Research Funding - Bayer (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Ferring
 
Thierry Andre Roumeguere
No Relationships to Disclose
 
Bernardo Herrera-Imbroda
No Relationships to Disclose
 
Lionel A. D'Hondt
Consulting or Advisory Role - Bayer; Janssen
 
Magali Quivrin
No Relationships to Disclose
 
Paolo Gontero
Honoraria - Astellas Oncology; Janssen; Photocure
Speakers' Bureau - Medac
Research Funding - Ferring
 
Salvador Villà
No Relationships to Disclose
 
Hussein Mustafa Khaled
No Relationships to Disclose
 
Beatrice Fournier
No Relationships to Disclose
 
Joanna Krzystyniak
No Relationships to Disclose
 
Yassin Pretzenbacher
No Relationships to Disclose
 
Hazal Erkol
No Relationships to Disclose
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Immunomedics; Janssen; Janssen (Inst); Loxo/Lilly; MSD Oncology; MSD Oncology (Inst); Pfizer/EMD Serono; Roche; Seagen; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Basilea (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Nektar (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen